Horshuns'ka M Iu, Karachentsev Iu I, Kravchun N O, Ĭensen É, Leshchenko Zh A, Hladkykh O I, Krasova N S, Tyzhnenko T V, Opaleĭko Iu A, Poltorak V V
Ukr Biokhim Zh (1999). 2013 May-Jun;85(3):10-21.
The authors' data and those from literature concerning biological role of fetuin A glycoprotein have been generalized in the article. A direct correlation has been established between fetuin A and some adipokines involved in the formation of insulin resistance and atherogenesis (progranulin, omentin-1), and osteoprotegerin (the novel cardiovascular risk factor) as well as an increase of circulating levels of fetuin A in patients with type 2 diabetes mellitus with high cardiovascular risk metabolic pattern but without manifestations of macrovascular complications. This substantiates the involvement of fetuin A in the complex of biomarkers of subclinical atherosclerosis.
本文总结了作者的数据以及文献中关于胎球蛋白A糖蛋白生物学作用的数据。已证实胎球蛋白A与一些参与胰岛素抵抗和动脉粥样硬化形成的脂肪因子(前颗粒蛋白、网膜素-1)、骨保护素(新型心血管危险因素)之间存在直接关联,并且在具有高心血管风险代谢模式但无大血管并发症表现的2型糖尿病患者中,胎球蛋白A的循环水平升高。这证实了胎球蛋白A参与亚临床动脉粥样硬化生物标志物复合体。